Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 279,400 shares, a decline of 5.5% from the January 15th total of 295,600 shares. Based on an average trading volume of 947,300 shares, […]
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) rose 5% during mid-day trading on Thursday . The stock traded as high as $0.49 and last traded at $0.47. Approximately 111,549 shares changed hands during mid-day trading, a decline of 93% from the average daily volume of 1,531,422 shares. The stock had previously closed at $0.44. […]
By Denny Jacob Dermata Therapeutics received a newly issued patent in Japan. Shares more than doubled in after-market trading. Applied Therapeutics said a.
By Denny Jacob Shares of Dermata Therapeutics more than doubled in post-market trading on Thursday following a newly issued patent in Japan. The stock rose.
Indian government granted permission for export of non-basmati rice via National Cooperative Exports Limited (NCEL), which allows the export to Kenya, Egypt, Madagascar, Comoros and Equatorial Guinea.